摘要高迁移率族蛋白B1(high mobility group box 1,HMGB1)在多种肿瘤组织中均有较高水平的表达,其与肿瘤细胞的增殖、分化、迁移及凋亡关系密切。由此看来,干扰HMGB1基因表达可有效抑制肿瘤细胞的增殖,这有望成为抗肿瘤治疗的新靶点。子宫内膜癌是女性最常见的恶性肿瘤之一,近年来发病率有上升趋势。本文将对近年来HMGB1在子宫内膜癌发生、发展、预后中的研究进展进行综述。
1 Colombo N,Creulzberq C,Amant F, et al.ESMO-ESGO-ESTRO consensus conference on endometrial cancer:Diagnosis,treatment and follow-up.Radiother Oncol,2015,117:559-581. 2 Tran AQ,Gehriq P.Recent Advances in Endometrial Cancer.F1000Res,2017,27:81. 3 Lola R,Benjamin D.S,Rhonda A,et al.Projecting cancer incidence and deaths to 2030:the unexpected burden of thyroid,liver,and pancreas cancers in the United States .Cancer Res,2014,74:2913-2921. 4 Talha S,Thomas MC,Mantia-Smaldone GM,et al.The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.Gynecol Onc,2016,141:434-439. 5 Rajmohan M,Robert AS,Britta W.Classification of endometrial carcinoma:more than two types.Lancet Oncl,2014,15:e268-278. 6 Robert JK,Dutta S,Fader AN,et al.WHO Classification of tumours of female reproductive organs.IARC Press,2014,32:114-119. 7 Goodwin HG,Clive S,Ernest WE.A new group of chromatin-associated proteins with a high content of acidic and basic amino acids.Eur J Bio,1973,38:14-19. 8 Marco E.Bi,Monica B.The role of HMG proteins in chromatine structure,gene expression and neoplasia.EMBO Rep,2000,109-114. 9 Yuan L,Rajendra P,Samuel HW.HMGB1:roles in base excision repair and related function.Biochim Biophys Acta,2010,1799:119-130. 10 Kang R, Chen RC,Zhang QZ,et al:HMGB1 in health and disease.Mol Aspects Med,2014,40:110-116. 11 Tang DL,Kang R,Zeh HJ,Lotze MT.High-mobility group box 1,oxidative stress,and disease.Antioxid Redox Signal,2011,14:1315-1335. 12 Kang R,Zhang Q,Zeh HJ,et al.HMGB1 in cancer:Good,bad,or both? .Clin Cancer Res,2013,19:4046-4057. 13 Chandrasekaran KS,Sathyanarayanan A,Karunagaran D.Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation,migration and invasion of human cervical and colorectal cancer cells.Tumour Biol,2016,37:13155-13166. 14 Zhu XW,Sun L,Wang YS.High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells.Acta Otolaryngol,2016,136:87-94. 15 Sasahira T,Kirita T,Oue N,et al.High mobility group box‐1‐inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.Cancer Sci,2008,1806-1812. 16 Taguchi A,Blood DC,Toro GD,et al.Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.Nature,2000,354-360. 17 马本红,张贵宇,梁静,等.高迁移率族蛋白 B1 在子宫内膜腺癌中的表达及意义.山东大学学报(医学版),2011,6:144-148. 18 冯力元,吴佳捷.小干扰RNA抑制HMGB1表达对子宫内膜癌细胞侵袭与迁移的影响.中南大学学报,2014,39:36-42. 19 刘心怡,吴佳捷.高迁移率族蛋白B1基因沉默抑制子宫内膜癌侵袭与转移的机制.中南大学学报,2016,41:251-257. 20 Luan XR,Ma CJ,Wang P,et al.HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-tomesenchymal transition.Onco Tarand Ther,2017,1389-1402. 21 Saxena N,Lahiri SS,Hambarde S,et al.RAS:target for cancer therapy.Cancer Invest.2008,26:948-955. 22 Downward J.Targeting RAS signalling pathways in cancer therapy.Nat Rev Cancer,2003,3:11-22. 23 Kargi A,Demirpence O,Gunduz S,et al.Serum levels of HMGB1 have a diagnostic role in metastatic renal cell cancer.Cancer Biomark,2016,17:17-20. 24 吴然然,吴佳捷.RNA干扰抑制HMGB1基因表达对子宫内膜癌的增殖抑制作用及其分子机制.中南大学学报,2014,39:673-680. 25 董毅飞,王旭,刁红录,等.甲基化转移酶抑制剂zebularine对人子宫内膜癌细胞ECC-1高迁移率族蛋白B1基因表达的影响.湖北医药学院学报,2016,35:342-344. 26 Zheng H,Chen JN,Yu X,et al.HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells.DNA Cell Biol,2016,35:622-627. 27 Bucciarelli LG,Kaneko M,Lee LK,et al.Receptor for advanced glycationend-products (RAGE)-mediated neurite outgrowth and activation of NF-kappa Brequire the cytoplasmic domain of the receptor but different downstream signaling pathways.Biol Chem,1999,274:19919-19924. 28 Sims GP,Rowe DC,Rietdijk ST.HMGB1 and RAGE in inflammation and cancer.Annu Rev Immunol Herbst R and Coyle AJ,2010,28:367-388. 29 Lee HJ,Kim A,Song IH,et al.Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.Pathol Int,2016,66:202-209. 30 Naugler WE,Karin M.NF-kappa B and cancer-identifying targets and mechanisms.Curr Opin Genet Dev,2008,18:19-26. 31 Schlueter C,Weber H,Meyer B,et al.HMGB1:an angiogenetic switch molecule.Am J Pathol,2005,1646:1259-1263. 32 Ying L,Hao J.Amphoterin-RAGE axis and tumor.Chinese Journal of Clinical Medicine,2004,6:270-272. 33 Maasch C,Vater A,Buchne K,et al.HMGA protein as therapeutic drug targets.Prog Cell Cycle Res,2003,285:279-286. 34 杜雪莲,盛修贵,颜春晓,等.子宫内膜癌组织 HEEC中肿瘤血管生成相关的差异表达基因的筛选及验证.中华妇产科杂志,2012,47:756-763. 35 Nguyen AH,Detty SQ,AgrawalKD.Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy:A Systematic Review.Anticancer Res,2017,37:1-7. 36 Yamada S,Maruyama I.HMGB1 a novel inflammatory cytokine.Clinica Chimica Acta,2007,375:36-42. 37 Paek J,Lee M,Nam JE,et al.Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.Arch Gynecol Obstet,2016,293:645-650. 38 Song JX,Lu JH,Liu LF,et al.HMGB1 is involved in autophagy inhibition caused by SNCA/alpha-synuclein overexpression:a process modulated by the natural autophagy inducer corynoxine B.Autophagy ,2014,10:144-154. 39 Huang J,Ni J,Liu K,et al.HMGB1 promotes drug resistance in osteosarcoma.Cancer Res,2012,72:230-238. 40 Ajabnoor GM,Crook T,Coley HM.Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells.Cell Death Dis,2012,3:e260. 41 Ran XM,Yang J,Liu CX,el at.MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy,Int J Clin Exp Pathol,2015,8:6617-6626.